Dow Up 0.76% Nasdaq Up 0.69%

XOMA Corporation (XOMA)

-NasdaqGM
4.30 Down 0.07(1.60%) Oct 24, 4:00PM EDT
Prev Close:4.37
Open:4.37
Bid:N/A
Ask:4.63 x 5000
1y Target Est:9.00
Beta:2.96
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:4.30 - 4.42
52wk Range:3.42 - 9.57
Volume:736,071
Avg Vol (3m):1,302,030
Market Cap:460.43M
P/E (ttm):N/A
EPS (ttm):-1.27
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
XOMADown 1.60%460.43M
NVSUp 1.02%218.72B
REGNUp 2.17%40.41B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):16.58
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.51
Quarterly EPS Est (Sep-14) :-0.17
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):-0.45

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

XOMA Corporation discovers and develops antibody-based therapeutics in the United States, Europe, and the Asia Pacific. Its proprietary products comprise gevokizumab, a humanized allosteric-modulating monoclonal antibody that binds to the inflamma... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback